	Cost-effectiveness of capivasertib plus abiraterone for PTEN-deficient metastatic hormone-sensitive prostate cancer in the United States. PLoS One Weiss GJ. PMID: 42932296 [PubMed - indexed for MEDLINE]
	Patient-Derived Organoids for Predicting Chemotherapy Response in Bladder Cancer: A Multicenter, Real-world Validation Study. Ann Surg Oncol Zhao Y, Zhang S, Wang Y, Shen Z, Feng J, Zou J, Hou J, Zhang X, Zhou Z, Yu N, Qu S, Chen J. PMID: 42932116 [PubMed - as supplied by publisher]
	[Bilateral serous chorioretinopathy under immune checkpoint treatment- : Diagnostic dilemma in possible bilateral diffuse uveal melanocytic proliferation (BDUMP) in lymphatic metastasized chromophobe renal cell carcinoma]. Ophthalmologie Senkulak T, Böker T, Aretz T. PMID: 42931923 [PubMed - as supplied by publisher]
	A dual signal amplification photothermal biosensor based on Sn-CDs/NPC and DNA walker for prostate cancer cell detection. Mikrochim Acta Zhang S, Li R, Tan H, Hao T, Wang S, Hu Y, Guo Z, Zhang Q. PMID: 42931874 [PubMed - indexed for MEDLINE]
	Human Papillomavirus and Prostate Cancer: A Controversial Association. Pathogens Sá S, Sousa M, Pereira AC, Baylina P, Cerqueira F. PMID: 42931222 [PubMed - indexed for MEDLINE]
	Preoperative Advanced Lung Cancer Inflammation Index and Acute Kidney Injury After Adult Cardiac Surgery: A Retrospective Cohort Study. J Cardiovasc Dev Dis Gan H, Zhang R, Fan R, Yin L, Ning S, Wang J, Liu D, Chen W, Chen X, Qiu Z. PMID: 42930886 [PubMed]
	From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review. Med Sci (Basel) Cutitaru AB, Caruntu ID, Balan RA, Solcan C, Amalinei C. PMID: 42930552 [PubMed - indexed for MEDLINE]
	[(177)Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing. Curr Oncol Buonerba C, Di Lorenzo G. PMID: 42930191 [PubMed - indexed for MEDLINE]
	Immune Checkpoint Inhibitor-Associated Pneumonitis in Patients Treated for Metastatic Renal Cell Carcinoma. Curr Oncol Masur J, Mullapudi A, Ali S, Fortune K, Bueno J, Battey T, Goudarzi A, Patel H, Sturek J, Devitt M, Skelton WP 4th, Dreicer R, Viscuse P. PMID: 42930183 [PubMed - indexed for MEDLINE]
	Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration. Curr Oncol Wang H, Zhang Y, Li Z, Wu J, Cao H, Gan L, Qiu X, Wang W. PMID: 42930175 [PubMed - indexed for MEDLINE]
	Exercise During Active Surveillance for Localized Low-Risk Prostate Cancer: Current Evidence and a Survivorship Framework. Curr Oncol Miller JA. PMID: 42930166 [PubMed - indexed for MEDLINE]
	Patient Journey and Treatment Patterns of Non-Muscle-Invasive Bladder Cancer in Mexico. Curr Oncol Scavuzzo A, Castillejos-Molina RA, Bravo-Castro I, Jiménez-Ríos MA, Campos-Salcedo JG, Jiménez-Dávila MA, Suaste-Carmona B, Flores-García LE, Ferreira D, Castillo V, Lugo-Martínez G, Rodríguez Covarrubias FT. PMID: 42930164 [PubMed - indexed for MEDLINE]
	Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer. N Engl J Med Powles T, Grande E, Simone G, Gómez de Liaño A, Maruzzo M, Velho PI, Kikuchi E, Vu TQ, Popovic L, Çil T, Gravis G, Radkowski R, Hernández LRN, Cutuli HJ, Bamias A, Bauernhofer T, Pavic M, Choi YJ, Chang CH, Kitamura H, Rosenberg JE, Rowbottom J, Ho S, Gupta A, Drakaki A, VOLGA Investigators. PMID: 42929692 [PubMed - as supplied by publisher]
	Real-World Characteristics and Early Outcomes of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma. Int J Urol Tsujino T, Tamura K, Taoka R, Miyake M, Kobayashi K, Sasaki Y, Ogawa K, Tatarano S, Katayama S, Kato M, Abe Y, Oda Y, Wada K, Furukawa J, Araki M, Enokida H, Shiraishi K, Inoue K, Inamoto T, Azuma H, West Japan Uro. PMID: 42929436 [PubMed - indexed for MEDLINE]
	Population-level diagnostic and radiation treatment trends of low-risk prostate cancer. Cancer Monda SM, Odayar V, Yin M, Gonzalez RT, Jaime-Casas S, Hopfensperger KM, Kendrick D, Mietzel MA, Mislmani M, Zaki M, McLaughlin PW, Morgan TM, Jackson WC, Schipper MJ, Heimburger DK, Bryant AK, Pierce LJ, Borza T, Dess RT. PMID: 42928983 [PubMed - indexed for MEDLINE]
	Uncertainty-aware hybrid model for reliable navigation guidance in prostate biopsy. Med Phys Soormally C, Beitone C, Troccaz J, Voros S. PMID: 42928638 [PubMed - indexed for MEDLINE]
	Molecular and Immune Features of Metastatic Prostate Cancer in Hispanic and Non-Hispanic American Men. Cancer Rep (Hoboken) Recio-Boiles A, Deshmukh SK, Everly CJ, Wu S, Estrada-Mendizabal RJ, Heath E, McKay RR, Miranti C, Batai K, Lee BR, Chipollini J. PMID: 42928456 [PubMed - indexed for MEDLINE]
	Real-World Safety and Effectiveness of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer: Final Analysis of the RAPIT Study. Target Oncol Huang CY, Huang CP, Huang YY, Huang SK, Lu K, Meng E, Huang SP, Lee MY, Hung SC, Chen F, Pang ST. PMID: 42928397 [PubMed - as supplied by publisher]
	Chromophobe renal cell carcinoma: addressing the translational gap toward precision oncology for advanced disease. J Transl Med Lei X, Dong R, Yin L, Wu Z, Wang L, He M. PMID: 42928313 [PubMed - indexed for MEDLINE]
	Comparative diagnostic accuracy of PSMA-PET versus conventional imaging for Initial T/N/M staging of intermediate- to high-risk prostate cancer: a patient-level paired bivariate meta-analysis. BMC Cancer Wu H, Zhang W, Yang L, Yan X, Song P, Dong Q. PMID: 42928137 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 182461

Page 1 of 9124



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy